$179.32 Nov 18, 2026 · market cap $280B
Astrazeneca trades at $179. Our two models put it at $118–$429 (base $429): between them. Owner earnings gives no value here, so the base is the Cash Flow model. The models disagree widely, so read the base with care.
Cash Flow $429 · Damodaran $118 · models run Nov 18, 2026
BULLISH · medium confidence · Aug 8, 2026 · 3 months ago, may be out of date
14 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app